Rebecca L Mather (Rebecca Mather)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Venues

Molecular oncology

Future oncology (London, England)

Epigenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Rebecca L Mather, Abhijit Parolia, Sandra E Carson, Erik Venalainen, David Roig-Carles, Mustapha Jaber, Shih-Chun Chu, Ilaria Alborelli, Rebecca Wu, Dong Lin, Noushin Nabavi, Elena Jachetti, Mario P Colombo, Hui Xue, Perla Pucci, Xinpei Ci, Cheryl Hawkes, Yinglei Li, Hardev Pandha, Igor Ulitsky, Crystal Marconett, Luca Quagliata, Wei Jiang, Ignacio Romero, Yuzhuo Wang, Francesco Crea
The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms. Molecular oncology 15 (7) (2021)
Perla Pucci, Erik Venalainen, Ilaria Alborelli, Luca Quagliata, Cheryl Hawkes, Rebecca L Mather, Ignacio Romero, Sushilaben H Rigas, Yuzhuo Wang, Francesco Crea
LncRNA HORAS5 promotes taxane resistance in castration-resistant prostate cancer via a BCL2A1-dependent mechanism. Epigenomics 12 (13) (2020)
Rebecca L Mather, Henry Andrews, Hardev Pandha, Elena Jachetti, Jake Micallef, Yuzhuo Wang, Francesco Crea
The Open University's first one-day symposium on treatment-emergent neuroendocrine prostate cancer. Future oncology (London, England) 16 (6) (2020)
Abhijit Parolia, Erik Venalainen, Hui Xue, Rebecca L Mather, Dong Lin, Rebecca Wu, Perla Pucci, Jason Rogalski, Joseph R Evans, Felix Feng, Colin C Collins, Yuzhuo Wang, Francesco Crea
The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program. Molecular oncology 13 (5) (2019)

Rebecca L Mather.css-eqlu8i{font-size:small;padding-left:4px;} (Rebecca Mather)

Publication Activity (10 Years)

Top Topics

Top Venues

Rebecca L Mather (Rebecca Mather)